- Lobbying
- Nicole AND Carelli'
Lobbying Arrangements Results for 'Nicole Carelli''
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to vaccine coverage and cost-sharing. |
Valneva USA, Inc.
Specialty vaccine company |
THE DASCHLE GROUP | |||
Details Equality in women's sports and growth of women's soccer |
Washington Spirit
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details Issues related to Section 301 tariffs; issues related to coverage and policy for medical devices for infant sleep. |
Happiest Baby, Inc
Medical device manufacturer |
THE DASCHLE GROUP | |||
Details Medicaid reimbursement for dental services. |
Western Dental Services, Inc.
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ | |||
Details Implementation of the Patient Protection and Affordable Health Care Act; funding for AHEC; workforce issues. |
Des Moines University
|
DLA Piper LLP (US) | |||
Details Development, deployment and regulation of air purification technology |
ActivePure Technologies, LLC
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; regulatory relief for low-wage hospitals; issues related to hospital reimbursement, generally. |
Ballad Health
|
THE DASCHLE GROUP | |||
Details Issues related to COVID-19 testing |
Innova Medical Group
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details Matters relating to the Treasury Department's legacy security program. |
Marathon Asset Management, Inc.
|
DLA Piper LLP (US) | |||
Details Issues related to pharmaceutical safety and efficacy. Issues related to pharmaceutical safety and efficacy, generally; FY25 DoD appropriations, issues related to pharmaceutical safety and efficacy. |
Valisure
|
THE DASCHLE GROUP | |||
Details Issues related to drug and consumer product quality and safety |
Valisure
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details S.803, Save Rural Hospitals Act; H.R.3635, Save Rural Hospitals Act of 2023; issues related to 340B program, generally; issues related to hospital reimbursement, generally. |
Ballad Health
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details Medicare reimbursement relating to plasma protein therapies; H.R. 2581, Preservation of Access for Seniors in Medicare Advantage Act of 2015, and H.R. 2570, Strengthening Medicare Advantage through... |
Plasma Protein Therapeutics Association
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ | |||
Details Medical countermeasure development, stockpiling, and funding; issues related to U.S. smallpox and monkeypox response. |
Chimerix, Inc.
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details Issues related to patient care navigation and veterans health care access. |
WellHive
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details Issues related to vaccine coverage and cost-sharing. |
Valneva USA, Inc.
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details FY2024 VA Appropriations and 2024 National Defense Authorization Act Lower Health Care Costs Act |
Accolade
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details Medical countermeasure development, stockpiling, and funding; issues related to vaccine cost-sharing; FY25 NDAA, provisions related to biothreat vaccinations. |
Bavarian Nordic Inc.
|
THE DASCHLE GROUP | |||
Details Respect for Marriage Act, H.R.8404 |
Freedom for All Americans
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details CMS staffing mandate; Issues related to staffing and workforce support, generally; policies impacting nursing homes and assisted living, generally. |
American Health Care Association
|
THE DASCHLE GROUP | |||
Details Issues related to H.R. 908, the Medicare Advantage Quality Payment Relief Act. |
Aetna
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details Matters relating to the Treasury Department's legacy security program. |
Institutional Credit Partners
Asset fund manager |
DLA Piper LLP (US) | |||
Details Issues related to antibiotic development and antimicrobial resistance. |
Antimicrobials Working Group
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details Issues related to supply chain modernization, EHRM implementation, and VistA modernization FY24 National Defense Authorization Act and FY24 Department of Defense appropriations, provisions related ... |
Cognosante
|
THE DASCHLE GROUP | |||
Details Medicaid block grant/per capita caps; health care for vulnerable populations, generally. Proposed change to public charge rule. |
The Jewish Federations of North America
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details Funding and prioritization of biodefense preparedness and response, generally; policy recommendations related to biodefense preparedness and response; reauthorization of the Pandemic and All-Hazard... |
Bipartisan Commission on Biodefense
|
THE DASCHLE GROUP | |||
Details Drug pricing proposals, generally; behavioral and mental health, generally; PBM oversight, generally; maternal health, generally Issues related to program cuts |
CVS Health
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details Medical countermeasure development, stockpiling, and funding; reauthorization of the Pandemic and All-Hazards Preparedness Act |
Bavarian Nordic Washington, DC, Inc.
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ | |||
Details FY16 Labor-Education-HHS Appropriations bills, issues related to the National Diabetes Prevention Program. H.R. 1192/S. 586, The National Diabetes Clinical Care Commission Act. |
Novo Nordisk, Inc.
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ | |||
Details Work Opportunity Tax Credit (WOTC). Implementation of the American Rescue Plan Act of 2021, Pub. L. No. 117-2. |
ADP, LLC
|
DLA Piper LLP (US) | |||
Details Issues affecting incentives for automobile purchase. |
CarMax
|
DLA Piper LLP (US) | |||
Details Medicare billing issue for patient-specific medications used in intrathecal pain pumps. |
AIS PainCare
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details CMS staffing mandate; issues related to staffing and workforce support, generally; policies impacting nursing homes, generally. |
American Health Care Association
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details Implementation of Public Law 111-148 and funding for community health centers. |
National Association of Community Health Centers
|
DLA Piper LLP (US) | |||
Details H.R. 1851/S. 881, Family Act of 2013. S. 959, Pharmaceutical Quality, Security and Accountability Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3204, the Drug Quality an... |
EMD Serono, Inc.
|
DLA Piper LLP (US) | |||
Details Health care financing. |
Coalition on Health Care
|
DLA Piper LLP (US) | |||
Details Funding and prioritization of biodefense preparedness and response, generally; policy recommendations related to biodefense preparedness and response; reauthorization of the Pandemic and All-Hazar... |
Bipartisan Commission on Biodefense
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details Issues related to Orphan drug designation; 21st Century Cures Initiative; Issues related to drug discovery and development; International Plasma Protein Awareness Week. H.R. 4800, Agriculture, Rura... |
Plasma Protein Therapeutics Association
|
DLA Piper LLP (US) | |||
Details Implementation of Public Law No. 111-148. |
Fresenius Medical Care
|
DLA Piper LLP (US) | |||
Details Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R. 5846, Protecting America from Seasonal and Pandemic Influenza Act; S. 3219, Pr... |
Coalition to Stop Flu
|
THE DASCHLE GROUP | |||
Details Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; prescription drug abuse. Issues related to Medicare/Medicaid reimbursements. |
Pfizer, Inc.
|
DLA Piper LLP (US) | |||
Details Federal funding and policy issues related to seasonal and pandemic influenza prevention, treatment, and response; H.R.5846, Protecting America from Seasonal and Pandemic Influenza Act; S.3219, Prot... |
Coalition to Stop Flu
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details Issues related to enrollment and program management |
Cognosante
|
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP | |||
Details Issues related to antibiotic development and antimicrobial resistance. |
Antimicrobials Working Group
|
THE DASCHLE GROUP | |||
Details Appropriations issues affecting Puerto Rico. Implementation of the American Recovery and Reinvestment Act of 2009, tax provisions; economic development and other tax issues; the American Jobs Act; ... |
Puerto Rico Federal Affairs Administration
|
DLA Piper LLP (US) | |||
Details Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S... |
Novo Nordisk Inc.
|
DLA Piper LLP (US) |